Literature cited
J. Baker, Progr. Biophys. Mol. Biol.,24, 177 (1972).
M. P. Blaustein, Rev. Physiol. Biochem. Pharmacol.,70, 33 (1974).
H. Reuter, Progr. Biophys. Mol. Biol.,26, 1 (1975).
R. A. Chizzonite and B. Zak, Science,213, 1508 (1981).
A. N. E. Zimmerman and W. C. Hulsmann, Nature,211, 646 (1966).
W. G. Nayler and P. Poole-Wilson, Basic Res. Cardiol.,76, 1 (1981).
T. Godfraind, Fed. Proc.,40, 2866 (1981).
S. Hagiwara, in: Dynamic Properties of Lipid Membrane and Bilayers (E. Eiseman, ed.), New York (1975), p. 359.
D. J. Triggle and C. R. Triggle, Chemical Pharmacology of the Synaps, Chap. IV, London (1976).
H. Reuter and H. Scholz, J. Physiol. (London),264, 17 (1977).
A. Wollenqerger and H. Will, Life Sci.,22, 1159 (1978).
H. Reuter, in: Ions, Cyclic Nucleotides, Cholinergy, Oxford (1979), p. 153.
J. G. Dobson, J. Ross, and S. E. Mayer, Circulat. Res.,39, 388 (1976).
H. Reuter, Naunym — Schmideberg's Arch. Pharmakol.,251, 401 (1965).
M. L. Entman and G. S. Levey, Circulat. Res.,25, 429 (1969).
W. H. Horl, H. P. Jennisen, U. Groschel-Stewart, et al., in: International Symposium on Calcium Transport in Contraction and Secretion. Proceedings, Amsterdam (1975), p. 535.
M. A. Kirshberger, M. Tada, D. J. Repke, et al., J. Mol. Cell. Cardiol.,4, 673 (1972).
G. I. Dorofeev, L. A. Kozhemyakin, and V. T. Ivashkin, Cyclic Nucleotides and Adaptation of the Organism [in Russian], Leningrad (1978), p. 47.
N. A. Fedorov, Biological and Clinical Significance of Cyclic Nucleotides [in Russian], Moscow (1979), p. 69.
M. L. Entman, Adv. Cyclic Nucleotide Res.,4, 163 (1974).
H. Scholz, in: Adrenergic Activators and Inhibitors (L. B. Szekeres, ed.), Pt. 1, Vol. 1 (1980), p. 651.
N. Van Breemen, B. R. Farinal, P. Casteels, et al., Phil. Trans. Roy. Soc.,265, 57 (1973).
H. Karaki and G. B. Weiss, J. Pharmacol. Exp. Ther.,211, 86 (1979).
M. C. Schaub and J. G. Watterson, Trends Pharmacol. Sci.,2, 279 (1981).
S. C. Batra, Biochim. Biophys. Acta,305, 428 (1973).
L. Hurwitz, Z. F. Fitzpatrik, G. Debbas, et al., Science,179, 384 (1973).
H. J. Schatzmann and F. F. Vincenti, J. Physiol. (London),201, 369 (1969).
B. D. Raufogalis, Canad. J. Physiol. Pharmacol.,57, 1331 (1979).
E. Cirafoli, V. Niggli, and J. T. Penniston, Ann. N. Y. Acad. Sci.,358, 159 (1980).
V. Niggli, E. S. Adunyah, J. T. Penniston, et al., J. Biol. Chem.,256, 395 (1981).
F. F. Vincenzi and F. L. Larsen, Fed. Prob.,39, 2427 (1980).
M. Tada, T. Yamamoto, and Y. Tonomura, Physiol. Rev.,58, 1 (1978).
L. De Meis and A. Vianna, Annu. Rev. Biochem.,48, 275 (1979).
G. Inesi, in: Membrane Transport in Biology (G. Giebisch et al., ed.), West Berlin (1979), p. 357.
T. Watanabe, D. Lewis, R. Nakamoto, et al., Biochemistry,20, 6617 (1970).
K. Repke, Klin. Wschr.,42, 157 (1964).
H. G. Glitsch, H. Reuter, and H. Scholz, J. Physiol. (London), 209, 25 (1970).
J. E. Ponce-Hornus and G. A. Langer, J. Mol. Cell Cardiol.,12, 1367 (1980).
G. A. Langer, Biochem. Pharmacol.,30, 3261 (1981).
A. Wollenberger and H. Will, Life Sci.,22, 1159 (1978).
A. Wollenberger and E.-G. Krause, Pharmacol. Future Man,5, 170 (1973).
G. A. Langer, K. D. Philipson, and D. M. Bers, in: Metabolism of the Myocardium [Russian translation], E. I. Chazov and H. E. Morgan, eds., Moscow (1981), p. 11.
A. Fleckenstein, Annu. Rev. Pharmacol. Toxicol.,17, 149 (1977).
A. Fleckenstein, G. Fleckenstein-Grun, and Y. K. Byon, Arzneim.-Forsch.,27, 562 (1977).
T. Godfrain, J. Physiol. (London),260, 21 (1976).
T. Thorens and G. Haeusler, Eur. J. Pharmacol.,54, 79 (1979).
J. Church and T. T. Zsoter, Canad. J. Physiol. Pharmacol.,58, 254 (1980).
R. G. Rahwan, M. F. Piascik, and D. T. Witiak, ibid.,57, 443 (1979).
A. Fleckenstein, H. Tritthar, H. J. Doring, et al., Arzneim.-Forsch.,22, 22 (1972).
A. Fleckenstein, in: Second International Adalat Symposium (W. Lochner, W. Brassoh, and G. Kroneberg, eds.), Berlin (1975), p. 56.
T. Ehara and R. Kaufmann, J. Pharmacol. Exp. Ther.,207, 49 (1978).
H. Mawzath, R. E. Teneick, T. F. McDonald, et al., Circulat. Res.,40, 408 (1977).
W. Trautwein, D. Pelzer, T. F. McDonald, et al., Naunyn-Schmiedelberg's Arch. Pharmakol.,317, 228 (1981).
J. Ruedy, Clin. Invest. Med.,4, 129 (1981).
M. Terai, T. Takenaka, and H. Maeno, Biochem. Pharmacol.,30, 375 (1981).
T. Takenaka and H. Maeno, Folia Pharmacol. Jpn.,74, 85 (1978).
V. A. Kreye, G. D. Baron, J. B. Luth, et al., Naunyn-Schmiedeberg's Arch. Pharmakol.,288, 381 (1975).
M. Spedding, ibid.,318, 234 (1982).
P. Polster and M. de Claviers, Biochem. Pharmacol.,30, 897 (1981).
J. Takayanagi, K. Koike, Y. Yoshida, et al., J. Pharm. Dynam.,4, 798 (1981).
P. L. Vaghy, D. Johnson, M. A. Matlib, et al., J. Biol. Chem.,25, 6000 (1982).
N. Morel and T. Godfraind, Arch. Int. Pharmacodynam.,236, 315 (1978).
S. Harigaya and A. Schwartz, Circulat. Res.,25, 781 (1969).
A. M. Katz and D. J. Repke, ibid.,21, 153 (1967).
S. Ebashi and M. Endo, in: Progress in Biophysics and Molecular Biology (J. A. V. Butler and D. Noble, eds.), New York (1968), p. 123.
P. Putriarca and E. Carafoli, J. Cell Physiol.,72, 29 (1968).
A. Scarpa and J. R. Williamson, in: Calcium Binding Proteins (W. Drabikowski, H. Strelecka-Golaszewska, and E. Carafoli, eds.), Amsterdam (1974), p. 547.
D. O. Levitskii, D. S. Verevolenskii, and T. S. Levchenko, in: Metabolism of the Myocardium fin Russian], E. I. Chazov and H. E. Morgan, eds., Moscow (1981), p. 35.
S. Ebashi, M. Endo, and J. Ohtsuki, Quart. Rev. Biophys.,2, 351 (1969).
A. M. Katz, Physiol. Rev.,50, 63 (1970).
R. J. Solaro, R. M. Wise, J. S. Shiner, et al., Circulat. Res.,34, 525 (1974).
G. A. Langer, Physiol. Rev.,48, 708 (1968).
K. Nishikori, T. Takenaka, and H. Maeno, Mol. Pharmacol.,13, 671 (1977).
K. Nishikori, T. Takenaka, and H. Maeno, Seikagaku,48, 367 (1976).
R. C. Webb and R. C. Bhalla, J. Molec. Cell. Cardiol.,8, 145 (1976).
R. Towart and E. Perzborn, Naunyn-Schmiedeberg's Arch. Pharmakol.,318, 249 (1982).
J. Church and T. T. Zsoter, Can. J. Physiol. Pharmacol.,58, 254 (1980).
J. Takayanagi, T. Hisayama, Y. Yoshida, et al., J. Pharm. Dynam.,3, 160 (1980).
J. Takayanagi, H. Yamashita, Y. Manda, et al., Jpn. J. Pharmacol.,27, 311 (1977).
T. Uruno, K. Tabata, M. Yamada, et al., ibid.,28, 155 (1978).
D. C. Pang, Biochim. Biophys. Acta,598, 528 (1980).
D. M. Bers and G. A. Langer, Am. J. Physiol.,237, H332 (1979).
R. D. Philipson, D. M. Bers, A. Y. Nishimoto, et al., ibid.,238, H373 (1980).
C. J. Limas, Arch. Biochem.,179, 302 (1977).
D. C. Pang and N. Sperelakis, Biochem. Pharmacol.,30, 2356 (1981).
M. T. Michelin, M. Cleucle, and P. Duchene-Marulaz, Therapie,32, 485 (1977).
C. Labrid, A. Grosset, G. Dureng, et al., J. Pharmacol. Exp. Ther.,211, 546 (1979).
S. Vogel, R. Crompton, and N. Sperelakis, ibid.,210, 378.
L. Cohen, J. Cardiovasc. Pharmacol.,3, 581 (1981).
D. L. Keefe, J. Pharmacol. Exp. Ther.,220, 91 (1982).
G. T. Bolger, P. J. Gengo, E. M. Luchowski, et al., Biochem. Biophys. Res. Commun.,104, 1604 (1982).
P. Bellemann, D. Ferry, F. Lübbecke, et al., Arzneim. Forsch.,31, 2064 (1981).
F. J. Ehlert, W. R. Roeske, E. Itoga, et al., Life Sci.,30, 2191 (1982).
L. T. Williams and P. Tremble, J. Clin. Invest.,70, 209 (1982).
F. Scholssman, H. Medenwald, and H. Rozenkranz, in: Second International Adalt Symposium, Berlin (1975), p. 33.
P. D. Henry, Am. J. Cardiol.,46, 1047 (1980).
K. M. M. Murphy and S. H. Shyder, Eur. J. Pharmacol.,77, 201 (1982).
P. Belleman, D. Ferry, F. Lubbecke, et al., Arzneim. Forsch.,31, 2064 (1981).
R. J. Gould, K. M. M. Murphy, and S. H. Synder, Proc. Natl. Acad. Sci. USA, Biol. Ser.,79, 3656 (1982).
J. S. Johnson, in: Cancer Medicine (J. F. Hollmand and F. Frei, eds.), Philadelphia (1973), p. 840.
K. G. Bensch and S. E. Malawista, J. Cell Biol.,40, 95 (1969).
J.-C. Stoclet, Blochem. Pharmacol.,30, 1723 (1981).
J. R. Dedman, R. L. Jackson, W. E. Schreibe, et al., J. Biol. Chem.,253, 343 (1978).
T. C. Vanaman, F. Sharief, and D. M. Watterson, in: Calcium Binding Protein and Calcium Functions (R. H. Wasserman, R. A. Coradino, E. Corafoli, et al., eds.), New York (1977), p. 107.
Ch. O. Brostrom and D. J. Wolff, Biochem. Pharmacol.,30, 1395 (1981).
K. Watanabe and W. L. West, in: First International Conference on Clinical Aspects of Cyclic Nucleotides, Vail, Colorado (1979).
D. J. Wolf and Ch. O. Bronstrom, Adv. Cyclic Nucleotide Res.,11, 27 (1979).
M. P. Walsh, C. J. Le Peuch, B. Vallet, et al., J. Mol. Cell. Cardiol.,12, 1091 (1980).
R. Dabrowsky, D. Aromatorio, J. M. Sherry, et al., Biochem. Biophys. Res. Commun.,78, 1283 (1977).
D. R. Hathaway and R. C. Adelstein, Proc. Natl. Acad. Sci. USA,76, 1653 (1979).
S. Forsen, E. Thulin, T. Drakenberg, et al., FEBS Lett.,117, 189 (1980).
S.-L. Bostrom, B. Ljung, S. Mordh, et al., Nature,292, 777 (1981).
J. Church and T. T. Zsotter, Can. J. Physiol. Pharmacol.,58, 254 (1980).
S. J. Thorens, Muscle Res. Cell Motility,1, 455 (1980).
P. Y. K. Wong and W. Y. Cheung, Biochem. Biophys. Res. Commun.,90, 473 (1979).
E. W. Sutherland, G. A. Robinson, and R. W. Butcher, Circulation,37, 279 (1968).
S. E. Mayer, D. H. Namm, and L. Rice, Circulat. Res.,26, 225 (1970).
G. J. Drummond and D. L. Severson, ibid.,44, 145 (1979).
H. P. Bar, Advanc. Cyc. Nucleotide Res.,4, 195 (1974).
G. L. Kramer and J. N. Wells, Mol. Pharmacol.,16, 813 (1979).
W. R. Kukowetz, S. Holzman, A. Wurm, et al., Naunyn-Schmiedeberg's Arch. Pharmakol.,310, 129 (1979).
C. Gruetter, D. Y. Gruetter, J. E. Lyon, et al., J. Pharmacol. Exp. Ther.,219, 181 (1981).
M. Endoh, K. Stach, and Sh. Yamashita, Eur. J. Pharmacol.,66, 43 (1980).
G. Haeusler, R. Eigenmann, and W. P. Burkard, Naunyn-Schmiedeberg's Arch. Pharmakol.,274, R48 (1972).
W. R. Kukowetz and G. Pöch, ibid., 267, 189 (1970).
G. Pöch and W. R. Kukowetz, Adv. Cyc. Nucleotide Res.,1, 195 (1972).
N. Nakamoto, M. Terai, T. Takenaka, et al., Biochem. Pharmacol.,27, 1269 (1978).
R. Anderson, L. Lundholm, E. Mohme-Lundholm, et al., Adv. Cyc. Nucleotide Res.,1, 213 (1972).
T. Takenaka, S. Usuda, T. Nomura, et al., Arzneim. Forsch.,26, 2172 (1976).
F. C. Greenslade, C. K. Scott, K. L. Newquist, et al., J. Pharm. Sci.,71, 94 (1982).
F. Ledda, P. Marchetti, and A. Manni, Pharmacol. Res. Commun.,3, 195 (1971).
Y. Kiura, I. Inui, and H. Mmamura, Naunyn-Schmeideberg's Arch. Pharmakol.,301, 201 (1978).
M. G. Caron and R. J. Lefkowitz, Nature,249, 258 (1974).
B. Rabinowitz, L. Chuk, M. Kligermen, et al., Am. J. Physiol.,229, 582 (1975).
M. Endoh and H. J. Schumann, Eur. J. Pharmacol.,30, 213 (1975).
F. Ledda, P. Marchetti, and A. Mugeli, Br. J. Pharmacol.,54, 83 (1975).
J. Shanfeld, M. E. Hess, and N. K. Levine, J. Pharmacol. Exp. Ther.,193, 317 (1975).
J. C. A. Van Meel, A. De Jonge, B. Eilfer, et al., Eur. J. Pharmacol.,69, 205 (1981).
J. C. A. Van Meel, A. De Jonge, H. O. Kalkman, et al., Naunyn-Schmiedeberg's Arch. Pharmakol.,316, 288 (1981).
M. August and F. V. De Fendis, Gen. Pharmacol.,13, 343 (1982).
J. G. Dobson, J. Ross, and S. E. Mayer, Circulat. Res.,39, 388 (1976).
H. Reuter, Naunyn-Schemiedberg's Arch. Pharmakol.,251, 401 (1966).
R. Niedergerke and S. Page, Proc. Roy. Soc. B,197, 333 (1977).
G. W. Beller and H. Reuter, J. Physiol. (London),207, 211 (1970).
A. Fabiato and F. Fabiato, Circulat. Res.,40, 119 (1977).
J. B. Bassingthwaighte and H. Reuter, in: Electrical Phenomena in the Heart (W. D. DeMello, ed.), New York (1972), p. 353.
R. W. Tsien, Adv. Cyc. Nucleotide Res.,8, 363 (1977).
F. J. Komarow, L. J. Olbinskaya, and P. F. Litvitsky, J. Mol. Cell. Cardiol.,12, Suppl. 1, 77 (1980).
P. F. Litvitskii, A. Kh. Kogan, and A. N. Kudrin, Farmakol. Toksikol., No. 3, 303 (1981).
Author information
Authors and Affiliations
Additional information
Translated from Khimiko-farmatsevticheskii Zhurnal, Vol. 18, No. 2, pp. 134–147, February, 1984.
Rights and permissions
About this article
Cite this article
Simkhovich, B.Z., Kimenis, A.A. Mechanism of action of cardiovascular drugs-calcium blockers (review). Pharm Chem J 18, 71–82 (1984). https://doi.org/10.1007/BF00758830
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00758830